Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.9600
-0.0500 (-4.95%)
At close: Mar 3, 2026, 4:00 PM EST
0.9300
-0.0300 (-3.12%)
Pre-market: Mar 4, 2026, 8:23 AM EST
Bio Green Med Solution Market Cap
Bio Green Med Solution has a market cap or net worth of $4.7 million as of March 4, 2026. Its market cap has increased by 124.01% in one year.
Market Cap
4.70M
Enterprise Value
871.14K
1-Year Change
124.01%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since May 5, 2004, Bio Green Med Solution's market cap has decreased from $73.90M to $4.70M, a decrease of -93.63%. That is a compound annual growth rate of -11.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 4.90M | -32.88% |
| Dec 31, 2025 | 7.30M | 204.17% |
| Dec 31, 2024 | 2.40M | 4.35% |
| Dec 29, 2023 | 2.30M | -72.62% |
| Dec 30, 2022 | 8.40M | -78.35% |
| Dec 31, 2021 | 38.80M | 2.11% |
| Dec 31, 2020 | 38.00M | 230.43% |
| Dec 31, 2019 | 11.50M | 51.32% |
| Dec 31, 2018 | 7.60M | -63.29% |
| Dec 29, 2017 | 20.70M | -8.00% |
| Dec 30, 2016 | 22.50M | 30.06% |
| Dec 31, 2015 | 17.30M | 6.13% |
| Dec 31, 2014 | 16.30M | -78.66% |
| Dec 31, 2013 | 76.40M | 45.80% |
| Dec 31, 2012 | 52.40M | 63.24% |
| Dec 30, 2011 | 32.10M | -54.85% |
| Dec 31, 2010 | 71.10M | 182.14% |
| Dec 31, 2009 | 25.20M | 231.58% |
| Dec 31, 2008 | 7.60M | -92.35% |
| Dec 31, 2007 | 99.40M | -20.16% |
| Dec 29, 2006 | 124.50M | 920.49% |
| Dec 30, 2005 | 12.20M | -75.65% |
| Dec 31, 2004 | 50.10M | -32.21% |
| May 5, 2004 | 73.90M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 5.74M |
| Calidi Biotherapeutics | 5.72M |
| Quince Therapeutics | 5.50M |
| Silexion Therapeutics | 5.41M |
| Processa Pharmaceuticals | 5.17M |
| Cyclerion Therapeutics | 4.95M |
| MetaVia | 4.91M |
| Silo Pharma | 4.75M |